These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10983783)

  • 41. Aggression and psychopathology in persons with severe or profound mental retardation.
    Bihm EM; Poindexter AR; Warren ER
    Res Dev Disabil; 1998; 19(5):423-38. PubMed ID: 9770254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ethical and pragmatic issues in the use of psychotropic agents in young children.
    Jensen PS
    Can J Psychiatry; 1998 Aug; 43(6):585-8. PubMed ID: 9729685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prescription of psychotropic medications for patients discharged from a psychiatric emergency service.
    Ernst CL; Bird SA; Goldberg JF; Ghaemi SN
    J Clin Psychiatry; 2006 May; 67(5):720-6. PubMed ID: 16841621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of psychopharmacology education on prescribing practices.
    Alexander B; Nasrallah HA; Perry PJ; Liskow BI; Dunner FJ
    Hosp Community Psychiatry; 1983 Dec; 34(12):1150-3. PubMed ID: 6642462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of fluoxetine on self-injurious behavior in the developmentally disabled: a preliminary study.
    Markowitz PI
    J Clin Psychopharmacol; 1992 Feb; 12(1):27-31. PubMed ID: 1552036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
    Ruedrich SL; Swales TP; Rossvanes C; Diana L; Arkadiev V; Lim K
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):132-40. PubMed ID: 18197952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Problem behavior and psychiatric impairment within a developmentally disabled population. III: Psychotropic medication.
    Jacobson JW
    Res Dev Disabil; 1988; 9(1):23-38. PubMed ID: 3353539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonambulatory persons with profound mental retardation: physical, developmental, and behavioral characteristics.
    Kobe FH; Mulick JA; Rash TA; Martin J
    Res Dev Disabil; 1994; 15(6):413-23. PubMed ID: 7871230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reliability of the assessment of dual diagnosis (ADD).
    Matson JL; Bamburg JW
    Res Dev Disabil; 1998; 19(1):89-95. PubMed ID: 9472137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Snoezelen room, Activities of Daily Living skills training, and Vocational skills training on aggression and self-injury by adults with mental retardation and mental illness.
    Singh NN; Lancioni GE; Winton AS; Molina EJ; Sage M; Brown S; Groeneweg J
    Res Dev Disabil; 2004; 25(3):285-93. PubMed ID: 15134793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Personalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology?
    Stahl SM
    CNS Spectr; 2008 Feb; 13(2):115-8. PubMed ID: 18227742
    [No Abstract]   [Full Text] [Related]  

  • 54. SPET in psychopharmacology.
    Moresco RM; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):205-14. PubMed ID: 16010255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study.
    Lesén E; Carlsten A; Skoog I; Waern M; Petzold M; Börjesson-Hanson A
    Int Psychogeriatr; 2011 Oct; 23(8):1270-7. PubMed ID: 21447258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacotherapy for mental health problems in people with intellectual disability.
    Ji NY; Findling RL
    Curr Opin Psychiatry; 2016 Mar; 29(2):103-25. PubMed ID: 26779860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risperidone for aggression and self-injurious behavior in adults with mental retardation.
    Cohen SA; Ihrig K; Lott RS; Kerrick JM
    J Autism Dev Disord; 1998 Jun; 28(3):229-33. PubMed ID: 9656134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A behavioral diagnostic paradigm for integrating behavior-analytic and psychopharmacological interventions for people with a dual diagnosis.
    Pyles DA; Muniz K; Cade A; Silva R
    Res Dev Disabil; 1997; 18(3):185-214. PubMed ID: 9220544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.
    Kearns MA; Hawley KM
    J Psychiatr Pract; 2014 Nov; 20(6):438-47. PubMed ID: 25406048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation.
    Sovner R; Fox CJ; Lowry MJ; Lowry MA
    J Intellect Disabil Res; 1993 Jun; 37 ( Pt 3)():301-11. PubMed ID: 8334322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.